Integrated Bioinformatics and In Vitro Metabolomics Reveal the Mechanism of Nicotinamide Metabolism-Related Genes in Uterine Corpus Endometrial Carcinoma
Year: 2026
Type: preprint
Abstract: Background Uterine corpus endometrial carcinoma (UCEC) is regarded as the second most common cancer and a leading cause of death among female cancer patients, primarily attributed to its atypical symptoms and high metastatic potential. Nicotinamide (NAM) metabolism plays an eventful role in the various tumors’ progression. Nevertheless, studies on the effect of NAM in UCEC are still limited. Methods Transcriptional and clinical data were obtained from the TCGA database. NAM metabolism-related genes (NMRGs) were identified using the Molecular Signatures Database. Cox regression analyses (both univariate and multivariate) were performed to construct the NMRS. The Cox proportional hazards model was used to evaluate the impact of clinicopathological factors and risk scores on survival outcomes. The immune microenvironment was assessed using the ESTIMATE and CIBERSORT methods, while enrichment analysis was conducted to explore biological significance. Finally, the anticancer effect of NAM on UCEC was confirmed through functional experiments and in vitro metabolomics. Results Four key prognostic genes—NAXE, PARP10, PTGIS, and SLC22A13—were identified, and a correlation was found between the expression levels of these genes and clinical prognosis. Furthermore, experimental validation confirmed that NAM inhibits cell proliferation by affecting cell metabolism. Conclusion This study presents a novel framework for identifying prognostic biomarkers and therapeutic targets in UCEC.
Source: Research Square
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7234999780
